APA (7th ed.) Citation

D'Amore, C., Borgo, C., Sarno, S., & Salvi, M. (2020). Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance. Cellular Oncology (2211-3428), 43(6), 1003. https://doi.org/10.1007/s13402-020-00566-w

Chicago Style (17th ed.) Citation

D'Amore, Claudio, Christian Borgo, Stefania Sarno, and Mauro Salvi. "Role of CK2 Inhibitor CX-4945 in Anti-cancer Combination Therapy – Potential Clinical Relevance." Cellular Oncology (2211-3428) 43, no. 6 (2020): 1003. https://doi.org/10.1007/s13402-020-00566-w.

MLA (9th ed.) Citation

D'Amore, Claudio, et al. "Role of CK2 Inhibitor CX-4945 in Anti-cancer Combination Therapy – Potential Clinical Relevance." Cellular Oncology (2211-3428), vol. 43, no. 6, 2020, p. 1003, https://doi.org/10.1007/s13402-020-00566-w.